Trazodone hydrochloride tablets can be withdrawn after 4 years of consumption.
The drug should be taken for a long time under the guidance of a specialist physician to slowly reduce the drug until the drug is discontinued, or under the guidance of a physician to choose other drugs to replace the treatment.
The drug belongs to the 5-hydroxytryptamine receptor antagonist and 5-hydroxytryptamine reuptake inhibitor class of antidepressants, and its antidepressant mechanism is to antagonize the 5-hydroxytryptamine receptor and inhibit the reabsorption of 5-hydroxytryptamine. It inhibits monoamine oxidase activity and has a sedative effect and a slight muscarinic effect.
It is commonly used clinically in patients with depression and in the treatment of patients with or without anxiety.
Adverse reactions such as dizziness, drowsiness, dry mouth, blurred vision, and nausea have been observed after administration.
It is contraindicated in patients who are allergic to any of the components of the product.
For adult patients who are using antidepressants for the treatment of major depressive disorder or depression coexisting with other psychiatric disorders should be closely watched for clinical deterioration and suicidal tendencies; blood pressure should be monitored during the use of the medication; the medication should not be used to drive a vehicle or high-altitude hazardous work, etc.; use with caution in pregnant women and breastfeeding women.